Giant Biogene Sets 28 May 2026 AGM; Board Proposes RMB0.539 Final Dividend, RMB0.671 Special Dividend and Auditor Change to KPMG

Bulletin Express05-06

Giant Biogene Holding Co., Ltd. has scheduled its annual general meeting for 28 May 2026 at 1:30 p.m. in Xi’an, Shaanxi Province.

Key resolutions to be tabled include:

• Financial Statements: Shareholders will consider the audited consolidated results, directors’ report and auditor’s report for the year ended 31 December 2025.

• Board Composition: The company seeks to re-elect executive directors Ms. Fang Juan, Ms. Zhang Huijuan and Ms. Yan Yubo, with authority for the board to set their remuneration.

• Auditor Appointment: Following the retirement of Ernst & Young, the board recommends appointing KPMG as the new independent auditor until the next AGM, with remuneration to be determined by the board.

• Share Mandates: – Share Repurchase Mandate permitting buy-backs of up to 10% of issued shares (excluding treasury shares) during the mandate period. – General Issuance Mandate allowing the board to allot and issue up to 20% of issued shares, exclusive of any shares repurchased. – Extension Mandate to increase the issuance limit by the number of shares repurchased, capped at an additional 10% of issued shares.

• Dividends: The board proposes a final dividend of RMB0.5390 per ordinary share and a special dividend of RMB0.6714 per ordinary share for the financial year 2025. The record date for dividend entitlement is 8 June 2026; the share register will be closed from 3 June 2026 to 8 June 2026.

Administrative details: • The share register will be closed from 22 May 2026 to 28 May 2026 (both days inclusive) for determining AGM attendance and voting rights; transfers must be lodged by 4:30 p.m. on 21 May 2026. • Proxy forms must reach Tricor Investor Services Limited by 1:30 p.m. on 26 May 2026. • All AGM resolutions will be decided by poll in accordance with Hong Kong Listing Rules.

As of the announcement date (6 May 2026), the board comprises five executive directors—Mr. Yan Jianya (Chairman), Ms. Ye Juan, Ms. Fang Juan, Ms. Zhang Huijuan and Ms. Yan Yubo—and three independent non-executive directors: Mr. Huang Jin, Mr. Shan Wenhua and Ms. Wong Sze Wing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment